Influenza vaccination: An unmet need in patients with diabetes

Clinical Diabetes

Volumn 25, Issue 4, 2007, Pages 145-149

  Schaffner, William ^a,b   Rehm, Susan J ^b,c   Elasy, Tom A ^d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b National Foundation for Infectious Diseases   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COMORBIDITY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISORDERS OF CARBOHYDRATE METABOLISM; EPIDEMIC; GLYCEMIC CONTROL; HEALTH CARE ACCESS; HEALTH CARE NEED; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PUBLIC HEALTH SERVICE; REVIEW;

EID: 37449004413     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.25.4.145     Document Type: Review

References (52)

1. Centers for Disease Control and Prevention: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 55:1-41, 2006
2. American Diabetes Association: Standards of medical care - 2007. Diabetes Care 30 (Suppl. 1):S4-S42, 2007
3. Centers for Disease Control and Prevention: Influenza and pneumococcal vaccination coverage among persons aged ≥ 65 years and persons aged 18-64 years with diabetes or asthma - United States, 2003. MMWR 53:1007-1015, 2004
4. Department of Health and Human Services: Healthy people [article online]. Available from http://www.healthypeople.gov. Accessed 26 April 2007
5. Centers for Disease Control and Prevention: U.S. Obesity trends 1985-2005 [article online]. Available from http://www.cdc.gov/nccdphp/dnpa/obesity/trend/ maps/index.htm. Accessed 30 April 2007
6. Centers for Disease Control and Prevention: National diabetes fact sheet, United States - 2005 [article online]. Available from http://www.diabetes.org/ diabetes-statistics.jsp. Accessed 30 April 2007
7. Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM: Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med 30:371-377, 2006
8. American Diabetes Association: The dangerous toll of diabetes [article online]. Available from http://www.diabetes.org/diabetes-statistics/dangerous- toll.jsp. Accessed 26 April 2007
9. Kendall DM, Hamel AP: The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Am J Manag Care 8 (Suppl.):S635-S653, 2002
10. Kendall DM, Bergenstal RM: Comprehensive management of patients with type 2 diabetes: establishing priorities of care. Am J Manag Care 7 (Suppl.):S327-S343, 2001
11. Kannel WB, McGee DL: Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 2:120-126, 1979
12. Sowers JR: Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158:617-621, 1998
13. Narayan KMV, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF: Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884-1890, 2003
14. National Center for Health Statistics: Fast stats from A to Z [article online]. Available from http://www.cdc.gov/nchs/fastats/deaths.htm. Accessed 29 April 2007
15. Treanor JJ: Influenza virus. In Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Mandell GL, Bennett JE, Dolin R, Eds. Philadelphia, Pa., Elsevier Churchill Livingstone, 2005, p. 2060-2085
16. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289:179-186, 2003
17. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, Fukuda K: Influenza-associated hospitalizations in the United States: 1979-1980 through 2000-2001 respiratory seasons. JAMA 292:1333-1340, 2004
18. Office of Technology Assessment: Cost effectiveness of influenza vaccination [article online]. Available from http://www.wws.princeton.edu/ota/ ns20/year_f.html. Accessed 29 April 2007
19. Patriarca PA, Strikas RA: Influenza vaccine for healthy adults? N Engl J Med 333:933-934, 1999
20. Williams WW, Hickson MA, Kane MA, Kendal AP, Spika JS, Hinman AR: Immunization policies and vaccine coverage among adults: the risk for missed opportunities. Ann Intern Med 108:616-625, 1988
21. Centers for Disease Control and Prevention: Epidemiology and Prevention of Vaccine-Preventable Diseases. 10th ed., Atlanta, Ga., Centers for Disease Control and Prevention, 2007
22. Cox NJ, Subbarao K. Influenza. Lancet 354:1277-1282, 1999
23. Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, Herrera G, Erdman D, Hall CB, Seither R, Griffin MR, the New Vaccine Surveillance Network: The under-recognized burden of influenza in young children. N Engl J Med 355:31-40, 2006
24. Monto AS: Influenza: quantifying morbidity and morality. Am J Med 82:20-25, 1987
25. Kavet J: A perspective on the significance of pandemic influenza. Am J Public Health 67:1063-1070, 1977
26. Loughlin J, Poulios N, Napalkov P, Wegmuller Y, Monto AS: A study of influenza and influenza-related complications among children in a large U.S. health insurance plan database. Pharmocoeconomics 21:273-283, 2003
27. Smith SA, Poland GA: Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care 23:95-108, 2000
28. Watkins PJ, Soler NG, Fitzgerald MG, Malins JM: Diabetic ketoacidosis during the influenza epidemic. BMJ 4:89-91, 1970
29. Bouter KP, Diepersloot RJ, van Romunde LK, Uitslager R, Masurel N, Hoekstra JB, Erkelens DW: Effect of epidemic influenza on ketoacidosis, pneumonia and death in diabetes mellitus: a hospital register survey of 1976-1979 in The Netherlands. Diabetes Res Clin Pract 12:61-68, 1991
30. Cameron AS, Roder DM, Esterman AJ, Moore BW: Mortality from influenza and allied infections in South Australia during 1968-1981. Med J Aust 142:14-17, 1985
31. Barker WH, Mullooly JP: Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 142:85-89, 1982
32. Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE, Casscells SW: Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 28:1205-1210, 2007
33. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
34. Hansen HH, Joensen AM, Riahi S, Malczynski J, Molenberg D, Ravkilde J: Short- and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era. Scand Cardiovasc J 41:19-24, 2007
35. Pozzilli P, Gale EA, Visalli N, Baroni M, Crovari P, Frighi V, Cavallo MG, Andreani D: The immune response to influenza vaccination in diabetic patients. Diabetologia 29:850-854, 1986
36. Diepersloot RJ, Bouter KP, van Beek R, Lucas CJ, Masurel N, Erkelens DW: Cytotoxic T-cell response to influenza A subunit vaccine in patients with type 1 diabetes mellitus. Neth J Med 35:68-75, 1989
37. McElhaney JE, Pinkoski MJ, Au D, Lechelt KE, Bleackley RC, Meneilly GS: Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine 14:539-544, 1996
38. Feery BJ, Hartman LJ, Hampson AW, Proietto J: Influenza immunization in adults with diabetes mellitus. Diabetes Care 6:475-478, 1983
39. Looijmans-Van Den Akker I, Verheij T, Buskens E, Nichol KL, Rutten G, Hak E: Clinical effectiveness of first and repeat influenza vaccinations in adult and elderly diabetic patients. Diabetes Care 29:1771-1776, 2006
40. Colquhoun AJ, Nicholson KG, Botha JL, Raymond NT: Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 119:335-341, 1997
41. Schade CP, McCombs MA: Influenza immunization and mortality among diabetic Medicare beneficiaries in West Virginia. W V Med J 96:444-448, 2000
42. Nichol KL, Wuorenma J, von Sternberg T: Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 158:1769-1776, 1998
43. Fedson DS, Wajda A, Nicol JP, Hammond GW, Kaiser DL, Roos LL: Clinical effectiveness of influenza vaccination in Manitoba. JAMA 270:1956-1961, 1993
44. Saah AJ, Neufeld R, Rodstein M, La Montagne JR, Blackwelder WC, Gross P, Quinnan G, Kaslow RA: Influenza vaccine and pneumonia mortality in a nursing home population. Arch Intern Med 146:2353-2357, 1986
45. Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, Rhodes PH: Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 121:947-952, 1994
46. Nguyen-Van-Tam JS, Ahmed AH, Nicholson KG, Pearson JCG: Reduction in hospital admissions for pneumonia, influenza, bronchitis, and emphysema associated with influenza vaccine during 1989-90 epidemic in Leicestershire, UK. In Options for the Control of Influenza II. Hannoun C, Klenk HD, Kendal AP, Rubin FL, Eds. Amsterdam, Excerpta Medica, 1993, p. 107-112
47. Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, Nichol KL: Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 35:370-377, 2002
48. American Diabetes Association: Influenza and pneumococcal immunization in diabetes [Position Statement]. Diabetes Care 27 (Suppl. 1):S111-S112, 2004
49. Nicholson KG, Stone AJ, Botha JL, Raymond NT: Effectiveness of influenza vaccination in reducing hospital admissions in people with diabetes. In Options for the Control of Influenza III. Brown LE, Hampson AW, Webster RG, Eds. Amsterdam, Elsevier Science, 1996, p. 113-118
50. American Heart Association, American College of Cardiology, National Heart, Lung, and Blood Institute, Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pearson T, Pfeffer MA, Taubert KA: AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 47:2130-2139, 2006
51. Lewis-Parmar H, McCann R: Achieving national influenza vaccine targets: an investigation of the factors affecting influenza vaccine uptake in older persons and people with diabetes. Commun Dis Public Health 5:119-126, 2002
52. Van Amburgh JA, Waite NM, Hobson EH, Migden H: Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 21:1115-1122, 2001